Previous 10 |
Overview With the equity markets trading at near record valuations, we’ve been actively looking for mispriced idiosyncratic opportunities, with the hope to find equity -like returns without equity risk. We believe that Merrimack Pharmaceuticals is such an investment. If we are right...
Original Post Editor's Note : The summary bullets for this article were chosen by Seeking Read more ...
Novo Nordisk finally breaks beyond the $50-60 barrier It was an ugly 4-5 years for Novo Nordisk ( NVO ). The ADRs surged above $50 in 2015, 2016, 2017 and 2018, only to falter badly and underperform a strong stock market (SPY) as well as the more recent rebound in the biotech sector ( IBB )....
Emisphere Technologies ( OTCPK:EMIS -5.9% ) announced that Alan Rubino, will retire as President and CEO effective as of October 15, 2019 and will be leaving the Company. More news on: Emisphere Technologies, Inc., Healthcare stocks news, Read more ...
ROSELAND, N.J., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCMKTS: EMIS) today announced that Alan L. Rubino, will retire as President and Chief Executive Officer (CEO) effective as of October 15, 2019 and will be leaving the Company. The Board of Director...
Introduction Novo Nordisk ( NVO ) is below its peak price set in Q1 2014. Can it resume its prior alpha generation versus the S&P 500 ( SPY ): Data by YCharts The article discusses whether the anticipated September FDA approval of an oral version of NVO's young hit diabetes drug Oz...
Background Novo Nordisk ( NVO ) has had a few self-inflicted wounds the past few years, exacerbated by a deflationary environment in the US diabetes market, especially since the insulin mega-blockbuster from Sanofi ( SNY ), Lantus, gained biosimilar competition. This affected pricing of NVO'...
Background Emisphere Technologies ( EMIS ) is an over-the-counter micro-cap biotech/pharmaceutical company that develops carriers for pharmaceutical companies that permit injectable therapeutics to be converted to oral tablets. The carriers allow transport of large molecules through the st...
News, Short Squeeze, Breakout and More Instantly...
Emisphere Technologies, Inc. Company Name:
EMIS Stock Symbol:
OTCMKTS Market:
ROSELAND, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (“Emisphere” or the “Company”) today announced the completion of the previously announced transaction whereby Novo Nordisk A/S (“Novo Nordisk”) (NYSE: NVO) acquired ...
Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against pharmaceutical company Emisphere Technologies, Inc. (OTC Ticker: EMIS). If you currently own shares of Emisphere and want to re...
ROSELAND, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (“Emisphere” or the “Company”) today announced that it has entered into a definitive agreement with Novo Nordisk A/S (“Novo Nordisk”), whereby Novo Nordisk will acquire E...